PHV-wordings
Diltiazem New
PSUR-outcome
|
24/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Venlafaxine New
PSUR-outcome
|
17/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amikacin New
PSUR-outcome
|
17/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Bemiparin New
PSUR-outcome
|
17/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Pholcodine New
Referral
|
16/03/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Esomeprazole/Naproxen New
PSUR-outcome
|
16/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Levomethadone New
PSUR-outcome
|
16/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Methadone New
PSUR-outcome
|
16/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Colistimethate sodium for intravenous use
PRAC signal recommendation
|
06/03/2023
Risk for Pseudo-Bartter syndrome. Further information and the changes to the product information in all EU languages are available on the EMA website.
Hydroxychloroquine
PSUFU
|
02/03/2023
Further information is available on the HMA-Website.
